Tim Hirst, PhD
Chairman and Chief Executive Officer
Tim is the Chairman & CEO of GPN Vaccines. He has extensive expertise in the life sciences, executive management and venture capital investment. Tim was previously CEO of ANU Connect Ventures, a $30M pre-seed VC fund, the Deputy Vice Chancellor for Research & Innovation at The University of Sydney and Professor & Head of Microbiology at the University of Bristol, UK. He is an active angel investor working with investment groups throughout Australia and US to assist early stage companies to raise capital and develop their innovative technologies. Tim is also Chairman of Gamma Vaccines Pty Ltd, Chairman of Brain Changer Pty Ltd, Director of Emudent Technologies Pty Ltd, Director of Flex-G Pty Ltd, Trustee Director of Griffin Accelerator Holdings Pty Ltd and an Honorary Adjunct Professor at the University of Adelaide.
Lauren Giorgio, PHD GAICD
Chief Operating Officer
Lauren is the Chief Operating Officer of GPN Vaccines. She brings valuable experience in intellectual property management, business development, stakeholder engagement, commercialisation and operations in the life sciences sector, having worked broadly across the pharmaceutical, medical device, digital health and diagnostic industries. Lauren has spent her career working alongside world-leading academics and clinicians to commercialise medical research. Most recently, she led the Business Development Office at the Centre for Eye Research Australia and prior to this, was part of the Business Development team at the internationally acclaimed Walter and Eliza Hall Institute. Lauren has also been involved in the establishment, management and strategic direction of several small companies including OccuRx, Enlighten Imaging and Catalyst Therapeutics.
Paul Wabnitz, MD PhD MBA
Paul has extensive clinical, drug development and business experience from both Australia and the United States. Until recently, Paul was Medical Director at CMAX where he provided leadership, training and management to over 70 clinical staff and has been an investigator on over 35 Phase 1 and 2 trials across a wide range of therapeutic areas. He has been Principal Investigator and Medical Monitor on a number of trials testing biologicals, antibodies, vaccines and other novel therapies. Paul also held various senior leadership roles at Pfizer Global in Michigan spanning clinical pharmacology, drug metabolism, pharmacokinetics, toxicology and clinical trial development. Paul is currently a Training Specialist in Medical Oncology and Clinical Pharmacology at the Royal Adelaide Hospital and Flinders Cancer Clinic. He is also a primary reviewer on the Human Research Ethics Committees for the Central Adelaide Local Health Network and also Bellberry.
Director, Regulatory & Quality
Jim has over 45 years’ experience in the manufacture, quality control, development and international regulatory requirements for vaccine products. He has been involved in more than 20 vaccine development projects as the lead regulatory advisor and preclinical safety expert, and has filed dozens of successful clinical trial applications in the US, Europe and Australia. Jim spent 26 years at CSL Limited in Melbourne where he held various leadership positions in vaccine manufacture, quality assurance and research and development, including Head of Regulatory Affairs for Vaccine Products. Following this, he became Vice President for the Biologics Consulting Group, an internationally recognized pharmaceutical regulatory consulting company, based in California. Jim is currently CEO of Global BioSolutions, an Australian company which provides regulatory and product development advice and assistance to biotech companies.
Eve Martin, LLB (Hons)
Company Secretary & General Counsel
Eve is an experienced commercial and operations professional, business development manager and intellectual property lawyer. She has worked extensively in universities, in private industry and for government. Eve also has significant Company Secretarial experience as the current Company Secretary for the Digital Health CRC Ltd and having been Company Secretary for FEI Company’s two Australian subsidiaries, FEI Australia Pty Ltd and FEI Melbourne Pty Ltd and providing advice in a legal capacity to many company boards and their secretaries. Eve has extensive experience advising companies in relation to intellectual property transactions and commercialisation including on matters relating to IP ownership, licensing, assignments, collaborations, alliances, sponsorships and Corporations Act compliance.